Articlo
Check my manuscript free

Taylor & Francis

Prepare your manuscript for Supramolecular Chemistry.

Review the checklist, choose your article type, and turn your draft into a cleaner submission package.

Checked 2026-08-02
Check readiness freePrepare this manuscript

Article types

Review
Clinical Trial
Research Article
Data Note
Lectio
Letter
Editorial
Methods Article
Protocol
Case Report
Systematic Review

Readiness requirements

Review the key details below, or download the complete checklist with every stored source-backed requirement.

Abstract length

  • Provide an author-written abstract of no more than 200 words.
  • Use a unstructured abstract.
Show 4 more
  • Should contain an unstructured abstract of 200 words.
  • Should contain a structured abstract of 250 words.
  • Trial registration numbers should be included in the abstract, with full details in the methods section.
  • There are no strict formatting requirements, but all manuscripts must contain the essential elements needed to evaluate a manuscript: abstract, author affiliation, figures, tables, funder information, and references.

Keywords

  • Provide 3-6 keywords chosen by the author.
  • Should contain between 3 and 6 keywords.

Reference style

  • Articlo formats your supplied references to the journal's stored style and checks that citations match the reference list; source validity is not verified.
  • For manuscripts submitted in LaTeX format a.bib reference file must be included.
Show 4 more
  • All bibliographic entries must contain a corresponding in-text citation.
  • Where applicable, this should include the hyperlink, DOI or other persistent identifier associated with the data set(s).
  • Readers should be able to interpret the table without reference to the text.
  • A declaration must be included within the submission stating: Confirmation the authors take full responsibility for the integrity of the whole content, including accuracy of references.

Figure and table rules

  • Keep every figure and table numbered, captioned, and cited in the manuscript.
  • Should not contain more than 20% of figures that are re-used (with appropriate permissions) from other sources.
Show 5 more
  • Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size).
  • All figures should include error bars where appropriate and include a description of how these errors were determined.
  • Figures should be of sufficient resolution to enable refereeing.
  • Tables should present new information rather than duplicating what is in the text.
  • Figures should be supplied in one of our preferred file formats: PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for figures that have been drawn in Word.

Funding statement

  • You should declare only the acquired funds and grants that are directly relevant to the work reported in your article; for example, This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].

Competing interests

  • Include or confirm the competing interests required by the journal. Articlo checks this item and flags anything that still needs author input.

Data availability statement

  • Add or confirm the author-written Data availability statement; Articlo flags it if author input is still needed.
  • Data Note: Further to the data sharing policy for the journal, Data Note submissions must include a DATA AVAILABILITY STATEMENT and describe data available via a REPOSITORY.

Ethics statement

  • Add or confirm the author-written Ethics statement; Articlo flags it if author input is still needed.
  • In settings where ethics approval for non-interventional studies (e.g. surveys) is not required, authors must include a statement to explain this.
Show 6 more
  • Authors should familiarise themselves with our policy on participant/patient privacy and informed consent.
  • All original research papers involving humans, animals, plants, biological material, protected or non-public datasets, collections or sites, must include a written statement in the Methods section, confirming ethical approval has been obtained from the appropriate local ethics committee or Institutional Review Board and that where relevant, informed consent has been obtained.
  • Consent All authors are required to follow the ICMJE requirements and Taylor & Francis Editorial Policies on privacy and informed consent from patients and study participants.
  • Authors must include a statement to confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any type of qualitative or quantitative research, has given informed consent to participate in the research.
  • Case Report: a clinical case report detailing their medical history, identifiable images or media content, etc), authors must include a statement to confirm that they have obtained written informed consent to publish the details from the affected individual (or their parents/guardians if the participant in not an adult or unable to give informed consent; or next of kin if the participant is deceased).
  • Case Report: For submissions where patients or participants can be potentially identified (e.g.

Cover letter

  • Using Third-Party Material You must obtain the necessary permission to reuse third-party material in your article.
  • The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission.
Show 1 more
  • If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission.

Author contributions

  • Submitting authors should be prepared to submit CRediT roles for themselves and their co-authors (where applicable) as part of the submission process.

Supplementary files

  • Lectio: Include every cited supplementary file and use matching labels in the manuscript.
  • Letter: Include every cited supplementary file and use matching labels in the manuscript.
Show 14 more
  • Review: Include every cited supplementary file and use matching labels in the manuscript.
  • Protocol: Include every cited supplementary file and use matching labels in the manuscript.
  • Data Note: Include every cited supplementary file and use matching labels in the manuscript.
  • Editorial: Include every cited supplementary file and use matching labels in the manuscript.
  • Case Report: Include every cited supplementary file and use matching labels in the manuscript.
  • Clinical Trial: Include every cited supplementary file and use matching labels in the manuscript.
  • Methods Article: Include every cited supplementary file and use matching labels in the manuscript.
  • Research Article: Include every cited supplementary file and use matching labels in the manuscript.
  • Embed or attach the author-supplied supplementary material so Articlo can extract and label it for the package.
  • If mass spectra data is provided in lieu of elemental analysis, accompanying evidence of homogeneity (e.g., 1 H NMR spectra and 13 C NMR) must also be provided in the Supporting Information.
  • These data should be submitted as Supporting Information.
  • The CIF file should also be provided as part of the Supporting Information.
  • If disorder is present, or if the model required the use of restraints, this should be described briefly in either the manuscript or Supporting Information.
  • A brief description of why such a program was used should be included in the manuscript or Supporting Information.

Title page and author information

  • All authors of a manuscript should include their full name and affiliation on the cover page of the manuscript.
  • One author will need to be identified as the corresponding author, with their email address normally displayed in the article PDF (depending on the journal) and the online article.

Article structure and word limits

  • All commercially available instruments should be referred to by their specific model numbers, for example, “Bruker Avance Neo 700 spectrometer”.
  • The weight and percentage should be separated by a comma – for example, the tetra-bromide X (0.631 g, 0.992 mmol, 50%).
Show 66 more
  • This should be presented in the form, mpt 65 °C (crystallised from MeOH).
  • C 12 H 21 O 3 required C, 67.6; H, 9.9% or (Found: C, 67.7; H, 9.8).
  • UV data should be given in the form λ max (EtOH)/nm 293 (ε/dm 3 mol -1 cm -1 27,700), 332 (21,400) and 402 (19,900).
  • If useful inflections and shoulders should be noted and specified as 228infl or 262sh.
  • IR data should be given in the form ν max /cm -1 3330 and 3150 (O–H), 1675 (C=O) and 1150 (C–O–C).
  • MS data should be given in the form: m / z 245 (M+, 75%), 217 (23%), etc. Thus, the molecular ion should be specified and relative intensities then given in parentheses.
  • Exact masses quoted for identification purposes should generally be accurate to within 5 ppm.
  • If comparison is to be made with literature values, these should be quoted in parentheses – for example, mpt 169 °C (lit., 11 168 °C), or ν max /cm -1 1795 and 1592 (lit., 12 1797 and 1602).
  • Data from titration studies to determine association constants (for example, using 1 H NMR, UV-vis or fluorescence spectroscopy) should be presented in the SI, for example in the form of stacked plots.
  • Should be no more than 3000 words.
  • Should be between 2500 and 4000 words.
  • It should be a maximum width of 525 pixels.
  • These instructions will ensure we have everything required so your paper can move through peer review, production and publication smoothly.
  • Note however that to satisfy image publication requirements (see below), the separate source image files ultimately must be included in the submission.
  • Authors should use their discretion as to when to upload these image files.
  • Experimental reporting requirements When submitting a manuscript, authors should provide all data required to understand and verify the research presented in the article.
  • X-Ray crystallographic data should also be deposited with the Cambridge Crystallographic Data Centre before submission.
  • Any unusual hazards due to chemicals, procedures or equipment should be identified clearly, for example using bolded, all-caps font ( HAZARD!… ).
  • Only non-standard apparatus and equipment should be described in full detail.
  • The accuracy of primary measurements should be provided.
  • Authors must provide full evidence for the homogeneity and identity of all new compounds synthesized.
  • Evidence for the unequivocal identification of new compounds should include acceptable elemental analysis data, and/or accurate mass data.
  • Spectroscopic information necessary for structural assignment is required.
  • In cases where mixtures of stereoisomers are generated the constitution of the mixture should be established using the appropriate analytical technique(s).
  • This should be given in parentheses after the compound name.
  • Instrument frequency, the solvent, and any standard should be specified.
  • The type of spectrum (field desorption, electron impact, etc.) should also be indicated.
  • Any revision changes must include revised CIFs and these revised CIFs must be deposited in the repository in question before the manuscript can be rereviewed.
  • Additionally, at submission authors must provide a CheckCIF report for crystal data.
  • All CIF files must contain the structure factors that were used in the refinement, as well as the refinement outputs and necessary experimental details.
  • If one of these programmes is used, this should be noted in the manuscript and CIF (by appending the created.sqf file to the end of the submitted CIF).
  • Non-linear regression analysis must be performed to derive association constants from experimental titration data.
  • Derived association constants should be reported alongside estimated errors.
  • Binding isotherms and residual plots should be included in the SI.
  • Your research funder or your institution may require you to publish your article open access.
  • Use our APC finder to view the APC for this journal.
  • Should be an authoritative review of a research topic or area of interest to the readership of Supramolecular Chemistry (see Aims & Scope ).
  • These should include adequate and appropriate validation to be considered.
  • Any datasets associated with the paper must publish all experimental controls and make full datasets available where possible.
  • If there are concerns about identifying factors in datasets, these should be discussed with the Editor-in-Chief prior to submission.
  • Please note, this is not required for submission but is encouraged.
  • Note that, regardless of the file format of the original submission, an editable version of the article must be supplied at the revision stage.
  • For all NIH/Welcome-funded papers, the grant number(s) must be included in the declaration of interest statement.
  • Clinical Trial: Clinical trials should be registered prospectively – i.e. before participant recruitment.
  • Authors of retrospectively registered trials must be prepared to provide further information to the journal editorial office if requested.
  • Clinical Trial: The clinical trial registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization.
  • All research studies on humans (individuals, samples, or data) must have been performed in accordance with the principles stated in the Declaration of Helsinki.
  • Please include all relevant safety precautions; and cite any accepted standard or code of practice.
  • You will also need to upload your LaTeX source files, which should be uploaded as a single zip file alongside your submission and marked as “LaTeX Source Files”.
  • A declaration must be included within the submission stating: Originality and accuracy of content has been confirmed by the authors.
  • Authors must provide full methodological details and adhere to relevant reporting guidelines where applicable.
  • Authors must retain the original and revised versions which must be shared upon request.
  • The PLSP guidelines for authors must be followed at all times.
  • Experimental data Authors should provide descriptions of the experiments in sufficient detail such that any skilled researcher is able to repeat/reproduce the described work.
  • For all spectra, δ values should be used.
  • Mutually coupled protons should be quoted with precisely matching J values so as to assist thorough interpretation, i.e. the average J value should be provided for both protons.
  • Authors should present their crystal data in a CIF (Crystallographic Information Framework) file format, which should be deposited with the Cambridge Crystallographic Data Centre (CCDC) before the article is submitted.
  • All “level A” alerts should be explained in the submission details for the article and an explanation provided within the submitted CIF, preferably using the Validation Reply Form (VRF).
  • Data Note: Data Notes should only describe the data.
  • Please use SI units (non-italicized).
  • Clinical Trial: Clinical Trials Registry In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository, ideally at the beginning of the research process (prior to participant recruitment).
  • The process of obtaining consent to publish should include sharing the article with the individual (or whoever is consenting on their behalf), so that they are fully aware of the content of the article before it is published.
  • Presentation of experimental data For each new compound presented, all pertinent data should be listed following the description of its preparation.
  • Authors should adhere to the following guidelines for the presentation of single crystal diffraction data.
  • Please do not embed it in the manuscript file but save it as a separate file, labelled GraphicalAbstract1.
  • Image descriptions are typically used by systems such as pronouncing screen readers to make images accessible to people that cannot read or see the object due to a visual disability.

Reporting guidelines

  • Include or confirm the reporting guidelines required by the journal. Articlo checks this item and flags anything that still needs author input.

Preprints and prior publication

  • If you have shared an earlier version of your Author’s Original Manuscript on a preprint server, please be aware that anonymity cannot be guaranteed.

Artificial intelligence disclosure

  • Add or confirm the author-written Artificial intelligence statement; Articlo flags it if author input is still needed.
  • Please include a statement disclosing whether and how generative AI has been used in the research and manuscript preparation process.
Show 6 more
  • Use of AI tools as part of ethical research studies is permitted.
  • A declaration must be included within the submission stating: The name and version number of the AI tool used.
  • Systematic Review: Use of AI tools as part of ethically conducted literature reviews, systematic reviews, meta-analysis and bibliometrics studies is permitted.
  • Use of AI tool assisted plain language summaries (PLS) of authors own work is permitted.
  • Please read our guidance on using AI tools in your research and manuscript preparation to understand scenarios where their use may be permissible, and the required information that must be disclosed.
  • A declaration must be included within the submission stating: Confirmation the authors have checked terms of use for the specific AI tool used, and therefore confirm suitability for publication.

Manuscript structure

  • Similarly, all tabulated results should be accompanied with a complete analysis of uncertainty in the presented data.
  • Linear regression analysis methods are considered outdated, introduce a number of errors, and should be avoided.
Show 5 more
  • Data Note: Data Notes do not include any interpretation or conclusion of the data (see preparing your paper).
  • Standard methods and techniques used throughout the described work should be given at the beginning of the experimental section; full descriptions of these are not necessary.
  • Relatedly, Job’s plot analyses are now recognised to be a flawed method to determine binding stoichiometry and should not be relied upon to choose an appropriate binding model.
  • Authors must retain full records of the methods undertaken, including full descriptions and records of the prompts used, which must be shared with the journal upon request.
  • Clinical Trial: However, for clinical trials that have not been registered prospectively, Taylor & Francis journals requires retrospective registration to ensure the transparent and complete dissemination of all clinical trial results which ultimately impact human health.

Study reporting guidelines

  • For animal studies, approval must have been obtained from the local or institutional animal use and care committee.
  • Authors must provide full methodological details and adhere to relevant reporting guidelines where applicable (e.g. CONSORT-AI, STARD-AI, GAMER, TRIPOD-AI, etc).
Show 1 more
  • Particular care should be taken in supporting the assignments of stereochemistry (both relative and absolute) of chiral compounds, for example by NMR spectroscopy, X-Ray crystallography, or correlation with known compounds of undisputed configuration.

Language and text style

  • Standard abbreviations for the signal multiplicity should be used (e.g., s, d, t, q, pentet…), whilst broad signals should be denoted by “br”.

Article type and manuscript length

  • Tables of crystallographic data should not be included in the main text of the paper.
  • Should be written with the following elements in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list).
Show 3 more
  • Should be written with the following elements in the following order: title page; abstract; keywords; main text introduction, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list).
  • Should be written with the following elements in the following order: title page; abstract; keywords; main text introduction, materials and methods, Data description, discussion; acknowledgements; declaration of interest statement; author contributions statement and ethics; data availability statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list).
  • Should be written with the following elements in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgements; declaration of interest statement; author contributions statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list).

Authorship and originality

  • Preparing Your Paper All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).

Blinded manuscript

  • The PDF should be uploaded as the “Manuscript - with author details”/“Manuscript - anonymous” file.
Save journal and get updates Download complete checklist

What your package checks

Abstract: 200 words
Keywords: 3-6 keywords
Declarations: Ethics, Artificial intelligence, Data availability

Source transparency

This preparation guide uses published journal-specific author requirements. Journal instructions can change, so authors should complete a final review before submission.

Open official guideline source